Press Releases

Cell Line and Membrane Market to See 5.1% Annual Growth Through 2023

Active R&D and Significant Investments Point to Industry Expansion

April 16, 2019

WELLESLEY, Mass., April 16, 2019–Increasing research and development activities, significant investments by pharmaceutical and biotech companies, and the increasing adoption of cell line technologies in cell-based assays are factors expected to contribute to growth in the cell line and membrane market, according to a BCC Research, “Cell Line and Membrane Market.”

The industry expects to see a compound annual growth rate (CAGR) of 5.1% through 2023, when it could be worth $220.3 million.

Major players in the market include Abzena (ABZA), Merck (MRK), BD Biosciences (BDX), Lonza Group (LONN), GE Healthcare (GE), and Corning (GLW).

Research Highlights

  • Cell lines will lead the market by size, with an expected 2023 value of $197.8 million, though cell membranes will lead the market by growth, with a CAGR through the period of 5.3%.
  • Cancer cell lines lead the market, valued at $51.1 million 2018, followed by immunotherapy cell lines at $31 million and ion channel cell lines at $21.6 million.
  • North America leads the market by both size and growth, with a 2018 value of $88.4 million and a CAGR through 2023 of 5.5%.

“Increasing investment in R&D in cell culture technology, high investments by pharmaceutical and biotechnology companies for drug development, and increasing adoption of cell line technologies in cell-based assays are some major factors that are expected to promote the growth of the global cell line and membrane market,” notes report author Sathya Durga.

United States Leads Market by Size and Growth

The United States currently leads the market by both growth and size, with a 2018 value of $102.3 million and a CAGR through 2023 of 5.7%. Growth is due to government efforts to promote CRISPR technology and investments which support drug development activities.

Editors/reporters requesting analyst interviews should contact Sarah Greenberg at press@bccresearch.com.

Cell Line and Membrane Market( BIO178A )
Publish Date:     

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.